Taconic is a global provider of genetically modified mouse and rat models and services. As a full-service industry leader, founded in 1952, Taconic helps clients acquire, test, develop, breed, cryopreserve, prepare, and distribute highly relevant research lines worldwide. Whether you require custom genetically engineered, humanized or research-ready models, Taconic's scientists will partner with you to rapidly and efficiently obtain the high quality models needed for your discovery or preclinical programs.
Taconic and InnoSer announced today that they have entered into a strategic alliance in which Taconic has granted rights to InnoSer to breed, sell, and distribute Taconic's C57BL/6NTac model in the Netherlands. The C57BL/6NTac (B6 Model) is widely applied in cardiovascular, obesity, aging, drug addiction, and alcoholism studies worldwide. It is one of Taconic's best-selling models.
Title: Preclinical in vitro and in vivo Evaluation of Combined Radiation Therapy
Date and time: July 9, 2013 at 11:00 AM ET
Speaker: Dr. Guillaume Serin,
Cellular Pharmacology Lab Director at
The Academy of Surgical Research
Dates: September 26-28, 2013
Location: Clearwater, Florida
Title: Preclinical mouse models to address vaccine efficacy in oncology
Date and time: June 12, 2013 at 11:00 AM ET
Speaker: Dr. Jean-Francois Mirjolet,
Technology Director at Oncodesign
Download the presentation today!
|% Issue free orders||98.89%|
|Corrective action closure (days)||22.47|
|% On-time shipments||99.88%|
|% project milestones on-time||93.18%|